Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric defense enzymes" is not a standard molecular target or specific entity in biomedical science. The term appears to be a non-canonical and overly broad descriptor, combining multiple unrelated protective mechanisms and enzymes found in the gastric environment. The **gastric mucosa**—the lining of the stomach—employs several defense mechanisms to protect itself from autodigestion and injury by gastric acid and digestive enzymes. This defense system consists of multiple components, including: - **Gastric mucus:** Secreted by mucous cells, it forms a protective layer that traps bicarbonate and neutralizes acid at the mucosal surface[1][5]. - **Bicarbonate secretion:** Neutralizes acid that penetrates the mucus layer, maintaining a near-neutral pH at the epithelial surface[1][5]. - **Gastric epithelial cells:** Provide a physical barrier and secrete mucus, playing a key role in defense[1]. - **Prostaglandins:** These hormonelike substances promote mucus and bicarbonate secretion, inhibit acid production, and support mucosal blood flow, contributing to cytoprotection[1][5]. - **Blood flow:** Adequate vascular supply is critical to provide nutrients and remove toxic metabolic products, supporting mucosal integrity[1]. As for **digestive enzymes in the stomach** (collectively referred to as "gastric enzymes"), these primarily include: - **Pepsin:** The main proteolytic enzyme, secreted as pepsinogen and activated by gastric acid[3][7]. - **Gastric lipase:** Breaks down fats, particularly important in infants[7]. - **Gastric amylase:** Minor role in starch digestion, more limited activity compared to pancreatic amylase[7]. - **Gelatinase and renin (chymosin):** Involved in protein and milk protein digestion, respectively, especially in infants[7]. None of these enzymes are individually called "gastric defense enzymes," and their roles in defense are indirect (by supporting digestion rather than direct mucosal protection)[3][7]. Drugs such as **omeprazole** and **lansoprazole** target the proton pump (H⁺/K⁺-ATPase) in gastric parietal cells to reduce acid secretion and are relevant in the therapeutic management of gastric injury and ulcers, not in targeting "gastric defense enzymes"[5]. In summary, "gastric defense enzymes" is not a precise molecular target but rather an inaccurate umbrella term covering both gastric protective mechanisms and digestive enzymes, which are distinct entities[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric defense enzymes.